colon and rectum cancer
Home Up Normal organs Evaluation slide (TEST SLIDE) Various cancers Normal organs and cancers prostate cancer Breast: cancer-metastasis-normal lung cancer Lung: cancer-metastasis-normal Normal lung tissue colon and rectum cancer colorectal: cancer-metastasis-normal Normal colon and rectum tissue larynx and pharynx cancer Ovary cancer Kidney cancer Stomach cancer Normal stomach tissue Esophagus cancer Liver cancer Liver: cancer-metastasis-normal Non-neoplastic liver tissue Thyroid cancer Lipomatous tumors Skin cancer Normal endometrium

 

  Category Human tissue array
   Cat. No. CD
   Product description colon and rectum cancer
   Data sheet CD1
CD1
     
   Images
  general_information
   No. of samples 59
   Text
Current version: CD1
Colorectal cancer: 59 cores

Price : 5 slide for 600 €

CD1  Human, colon and rectal cancer
               
  Age  Sex site Pathology TNM Stage No. of
CDN1#
1 60 F ascending  adenocarcinoma, M/D T3N0M0 101
2 58 F rectum adenocarcinoma, M/D T3N1MX 102
3 51 M transverse adenocarcinoma, P/D T3N0M0 103
4 38 F transverse adenocarcinoma, M/D T3N0M0 104
5 56 M sigmoid adenocarcinoma, W/D T3N2M0 105
6 46 F cecum adenocarcinoma, M/D T2N1M0 106
7 61 M cecum adenocarcinoma, mucinous T3N0M0 107
8 40 F sigmoid adenocarcinoma, W/D T3N2M0 108
9 36 F descending adenocarcinoma, M/D T3N0M0 109
10 68 M sigmoid adenocarcinoma, M/D T3N1M0 110
11 62 F sigmoid adenocarcinoma, M/D T3N0M0 111
12 65 M ascending adenocarcinoma, W/D T3N2M0 112
13 65 M sigmoid adenocarcinoma, M/D T3N0M0 113
14 72 F sigmoid adenocarcinoma, W/D T3N1M0 114
15 63 M ascending adenocarcinoma, W/D T3N0M0 115
16 73 F transverse adenocarcinoma, M/D T3N0M0 116
17 60 M sigmoid adenocarcinoma, M/D T3N0M0 117
18 65 F cecum adenocarcinoma, mucinous T3N2M0 118
19 57 M sigmoid adenocarcinoma, M/D T3N0M1 119
20 58 M cecum adenocarcinoma, M/D T3N0M0 120
21 56 M ascending adenocarcinoma, mucinous T3N0M0 121
22 57 M sigmoid adenocarcinoma, M/D T3N0M0 122
23 56 M ascending adenocarcinoma, M/D T4N1M0 123
24 36 M transverse adenocarcinoma, M/D T3N2M0 124
25 65 F sigmoid adenocarcinoma, W/D T3N0M0 125
26 62 M ascending adenocarcinoma, M/D T3N0M0 126
27 57 F sigmoid adenocarcinoma, W/D T3N1M0 127
28 78 M sigmoid adenocarcinoma, W/D T3N1M0 128
29 45 M rectum adenocarcinoma, W/D T3N1M0 129
30 65 M ascending adenocarcinoma, W/D T3N1M0 130
31 61 M transverse adenocarcinoma, mucinous T3N0M0 131
32 52 M rectum adenocarcinoma, M/D T3N0M1 132
33 52 F sigmoid adenocarcinoma, M/D T2N2M0 133
34 47 F cecum adenocarcinoma, M/D T3N0M0 134
35 63 F descending adenocarcinoma, M/D T3N1M0 135
36 53 M cecum adenocarcinoma, M/D T3N1M0 136
37 53 F transverse adenocarcinoma, W/D T3N0M0 137
38 64 M sigmoid adenocarcinoma, M/D T3N1M0 138
39 59 M sigmoid adenocarcinoma, M/D T4N0M0 139
40 57 M ascending adenocarcinoma, M/D T4N0M0 140
41 46 F ascending adenocarcinoma, P/D T3N2MX 141
42 59 M ascending adenocarcinoma, M/D T3N0M0 142
43 35 F ascending adenocarcinoma, mucinous T3N0M0 143
44 42 M transverse adenocarcinoma, M/D T3N2M0 144
45 49 F ascending adenocarcinoma, M/D T3N2M0 145
46 76 M sigmoid adenocarcinoma, M/D T3N1M1 146
47 74 M ascending adenocarcinoma, M/D T3N0M0 147
48 60 F rectum adenocarcinoma, M/D T4N0M0 148
49 62 M sigmoid adenocarcinoma, M/D T3N2M1 149
50 62 M sigmoid adenocarcinoma, M/D T3N0M0 150
51 57 M sigmoid adenocarcinoma, M/D T3N0M0 151
52 56 F sigmoid adenocarcinoma, M/D T3N2M1 152
53 75 F rectum adenocarcinoma, W/D T3N1M0 153
54 58 M rectum adenocarcinoma, M/D T3N0MX 154
55 56 M ascending adenocarcinoma, M/D T3N1M0 155
56 35 M rectum adenocarcinoma, M/D T2N1M0 156
57 34 M ascending adenocarcinoma, M/D T3N1M0 157
58 60 M transverse adenocarcinoma, W/D T3N0M0 158
59 70 M descending adenocarcinoma, M/D T3N0M0 159
60 carbon            
               
*WHO classification     W/D: well differentiated      
        M/D: moderately differentiated      
        P/D: poorly differentiated      
#: The normal tissue in CDN1 array of corresponding number is from the identical patient.      
TNM classification : colon and rectum carcinoma (AJCC 5 th Edition)      

General Information of the Tissue Array Slide :

Applications

  • 􀁺 Immunohistochemistry
  • 􀁺 In situ hybridization, RNA or DNA
  • 􀁺 Fluorescent in situ hybridization (FISH)
  • 􀁺 In situ PCR, RNA or DNA
  • 􀁺 TUNEL for apoptosis (Recommended procedures in www.tissue-array.com -> protocol)

Storage and stability

  • 􀁺 Individual slide is paraffin-coated and put in an air-tight pack with inert gas.
  • 􀁺 Tissue array slides are shipped in room temperature.
  • 􀁺 If the slides are stored in 4 degree, they are good up to one year.

How processed

  • 􀁺 Tissues were initially fixed with formalin except for some of the animal tissues.
  • 􀁺 Then, dehydrated with gradient ethanol; typically 1 hour each progressive steps; 70%, 90%, 95%, 99%, 100% x 3 times.
  • 􀁺 Cleared by xylene, three changes for 1 hour each.
  • 􀁺 Infiltrated with 60°C paraffin, three changes for 1 hour each
  • 􀁺 Microtoming in 4 µm thickness and put on silane coating slide from Muto Pure Chemicals (Japan)

Before use

  • 􀁺 Dry slides for 1 hour in a oven at 60 degree.
  • 􀁺 Dewax slides in xylene for 4 minutes x 5 times
  • 􀁺 Hydrate slides in 100%, 95% and 75% ethanol for 3 minutes x 2 times each.
  • 􀁺 Immerse slides in tap water for 5 minutes

Slide orientation

  • 􀁺 In most of the slides with 59 or 60 cores, the orientation is as below unless indicated otherwise. #60 location is usually filled with carbon for orientation.

Shaded area

1 2 3 4 5 6 7 8 9 10
11 12 13 14 15 16 17 18 19 20
21 22 23 24 25 26 27 28 29 30
31 32 33 34 35 36 37 38 39 40
41 42 43 44 45 46 47 48 49 50
51 52 53 54 55 56 57 58 59 60